EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review

Maria Forslund iD, Johanna Melin, Simon Alesi, Terhi Piltonen, Daniela Romualdi iD, Chau Thien Tay, Selma Witchel, Alexia Pena iD, Aya Mousa, Helena Teede iD

Clinical Endocrinology · 2023-07 · 99 (1) · 79-91

DOI: 10.1111/cen.14913 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Endocrinology, online erschienen am 27.03.2023. Verfasst von Maria Forslund und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Finska Läkaresällskapet, Orionin Tutkimussäätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

As part of the update of the International Evidence‐Based Guidelines for the Assessment and Management of polycystic ovary syndrome (PCOS), a systematic review was performed to inform evidence‐based recommendations.

Design

Systematic review. Only randomised controlled trial were included. Patients Women with PCOS; the use of combined oral contraceptive pills (COCP) was compared with no medical treatment.

Measurements

Outcomes were designed in collaboration with clinical experts, researchers, and consumers. Critical outcomes included hirsutism, irregular cycles, quality of life, body mass index (BMI), and weight.

Results

1660 publications were identified, but only four studies were included. No studies could be combined for meta‐analysis. COCP treatment improved cycle regularity compared with no medical treatment (100% vs. 0%, with low certainty of evidence). COCP showed no difference in improvement of hirsutism or BMI compared with placebo or lifestyle; a lower weight after COCP compared with no treatment (mean difference [MD] −8.0 (95% confidence interval, CI −11.67); −4.33 kg); and improvement in quality of life (MD 1.2 [95% CI 0.96]; 1.44), but these results were all very low certainty of evidence.

Conclusion

Results show that COCP benefit cycle regulation, but other benefits or potential adverse effects were only identified with very low certainty of evidence. The COCP is frontline medical treatment in PCOS, but this is still based on established efficacy in the broader general population. Our results show that research in PCOS is seriously lacking and should be prioritised to capture core reproductive, metabolic and psychological outcomes important in PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeFemaleHumansContraceptives, Oral, CombinedHirsutismQuality of Life

Stichwörter der Autor:innen

combined oral contraceptive pillshyperandrogenismirregular cyclespolycystic ovary syndrometreatment

Substanzen

Contraceptives, Oral, Combined

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Monash Centre for Health Research & Implementation, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victori, Australia.
  • Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Department of Obstetrics and Gynecology, Research Unit of Clinical Medicine and Medical research Centre, Oulu University Hospital, University of Oulu, Oulu, Finland.
  • Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy.
  • Department of Pediatrics, Division of Pediatric Endocrinology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Maria Forslund, Daniela Romualdi, Alexia Pena, Helena Teede

Förderung

  • National Health and Medical Research Council
  • Finska Läkaresällskapet
  • Orionin Tutkimussäätiö

Zitieren

APA

Forslund, M., Melin, J., Alesi, S., Piltonen, T., Romualdi, D., Tay, C. T., Witchel, S., Pena, A., Mousa, A., & Teede, H. (2023). Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review. Clinical Endocrinology, 99(1), 79-91. https://doi.org/10.1111/cen.14913

Vancouver

Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay CT, et al. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review. Clinical Endocrinology. 2023;99(1):79-91. doi:10.1111/cen.14913

BibTeX
@article{Forslund2023,
  author = {Forslund, Maria and Melin, Johanna and Alesi, Simon and Piltonen, Terhi and Romualdi, Daniela and Tay, Chau Thien and Witchel, Selma and Pena, Alexia and Mousa, Aya and Teede, Helena},
  title = {Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review},
  journal = {Clinical Endocrinology},
  year = {2023},
  volume = {99},
  number = {1},
  pages = {79--91},
  doi = {10.1111/cen.14913}
}
Kostenlos starten →